Pato Pato A, Costa Arpin E, Rodriguez Regal A, Rodriguez Constenla I, et al. Progression of a series of patients with relapsing-remitting multiple sclerosis treated for 7 years with natalizumab using the "no evidence of disease activity" parameter. Neurologia (Engl Ed) 2021;36:346-352.
PMID: 34714232